Discovery of activated protein C leads to lifesaving drug

University of Vermont College of Medicine Professor of Biochemistry George L. Long, Ph.D., received the Inventor of the Year Award, one of the nation's most prestigious awards for breakthrough inventions given by the Intellectual Property Owners Association (IPO) at an annual ceremony held June 5 in Washington, D.C.

Long was one of a team of scientists who shared the 29th Annual Inventor of the Year Award for their invention of the lifesaving drug Xigris (drotrecogin alfa (activated)). Developed by Eli Lilly & Company, Xigris was approved in November 2001 by the U.S. Food and Drug Administration (FDA) as a treatment for adults with life-threatening severe sepsis a blood disease that afflicts about 750,000 Americans each year, 215,000 of whom die as a result. Presenting the award was Vermont Senator Patrick Leahy, who was the recipient of the IPO Legislator of the Year award for his strong support of the intellectual property legislation passed by Congress in recent years.

Long came to the University of Vermont (UVM) in 1986 after working as a Senior Research Scientist at Eli Lilly & Company, where his laboratory work on the gene for human protein C and its role in controlling blood clotting and thrombosis earned him a patent and laid the foundation for Lilly's development of activated protein C through FDA approval.

"It is rewarding to see that work begun in my laboratory over 20 years ago has led to a treatment that is saving lives around the world," said Long. "I'm so honored to receive this award, and hope it will serve as an inspiration to other scientists doing important research in the basic sciences."

At the UVM College of Medicine, Long continues to look at human protein C as a factor in blood clotting and thrombosis. For the past 15 years, he has also done research to determine the molecular nature of mutations in the gene for this protein by looking at DNA from the blood of individuals who have hereditary thrombophilia

Contact: Jennifer Nachbur
University of Vermont

Page: 1 2

Related biology news :

1. Discovery of new shrimp species adds to unique family
2. Discovery of tiny microbes in ancient Greenland glacier may define limits for life on Earth
3. Discovery in parasite movement may offer insights into malaria
4. Scientists find second way to kill cancer cells: Discovery opens possibilities for new therapies
5. GlaxoSmithKline Drug Discovery and Development Research Grant Program 2004
6. Discovery helps explain how cells package DNA
7. Discovery offers clues to origin of life
8. Discovery could improve anemia treatment in patients
9. Discovery could lead to better treatment for cryptosporidum infections
10. Discovery of brain disorder gene paves way for genetic test
11. Discovery may be first plant cell surface molecule that halts cell proliferation

Post Your Comments:

(Date:8/7/2020)... ... 06, 2020 , ... Alucio™, a fast-growing provider of cloud-based ... and Jessica Wong have joined the company’s leadership team as Vice President of ... heads development efforts for Alucio’s flagship product, Beacon, an innovative cloud-based content management ...
(Date:8/7/2020)... ... August 06, 2020 , ... Nine middle school ... STEM Scholar Program, a unique professional development program that provides advanced STEM (science, ... school science teachers nationwide. , Created in partnership between the National Stem Cell ...
(Date:8/5/2020)... ... ... Regenative Labs has received approval from the Centers for Medicare & Medicaid Services ... jelly allografts to be assigned a Q code and be approved for application directly ... allograft product to be recognized as a 361 HCT/P by CMS regulated under 21CFR ...
Breaking Biology News(10 mins):
(Date:8/7/2020)... ... August 06, 2020 , ... VGXI, a highly ... closed on the purchase of greenfield for a new, expanded manufacturing facility. The ... 21 acres in the initial acquisition, with an option to purchase an additional ...
(Date:8/3/2020)... , ... August 03, 2020 , ... ... today announced Jim Corrigan, President and CEO has been named one of the ... cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how they ...
(Date:8/3/2020)... ... 2020 , ... Introducing Ardent Animal Health – MediVet Biologics rebrands company and ... Known as MediVet Biologics since its formation in 2016, the company is relaunching itself ... will build on its base of innovative therapies for osteoarthritis and cancer. ...
(Date:7/31/2020)... ... ... R3 Stem Cell International is now offering patients the opportunity to receive four ... may choose which extremities they would like treated. , Several studies have shown just ... R3 International, umbilical cord tissue is obtained from a lab with a long history ...
Breaking Biology Technology:
Cached News: